Prospective, randomized trial of trimethoprim/sulfamethoxazole vs. pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis: discussion

Ophthalmology. 2005 Nov;112(11):1882-4. doi: 10.1016/j.ophtha.2005.09.026.

Author

Gary N Holland¹

Affiliation

¹ Ocular Inflammatory Disease Center, Jules Stein Eye Institute, and Department of Ophthalmology, David Geffen School of Medicine at UCLA, Los Angeles, California 90095-7003, USA. uveitis@jsei.ucla.edu

PMID: 16271316
DOI: 10.1016/j.ophtha.2005.09.026

No abstract available

Publication types

Comment
Comparative Study

MeSH terms

Antiprotozoal Agents / therapeutic use*
Humans
Prospective Studies
Pyrimethamine / therapeutic use*
Randomized Controlled Trials as Topic
Sulfadiazine / therapeutic use*
Toxoplasmosis, Ocular / drug therapy*
Toxoplasmosis, Ocular / physiopathology
Treatment Outcome
Trimethoprim, Sulfamethoxazole Drug Combination / therapeutic use*

Substances

Antiprotozoal Agents
Sulfadiazine
Trimethoprim, Sulfamethoxazole Drug Combination
Pyrimethamine